- Amazon could be getting into healthcare, and the company's reportedly had conversations with generic drugmakers about it,
- It's the latest hint in recent months that Amazon is serious about healthcare. Worry about the prescription drug business being Amazon'd has sent healthcare stocks tumbling, and is even credited with sparking the
- Conversations with generic drugmakers could mean that Amazon is interested in either helping generic drugmakers distribute prescriptions to pharmacies or by selling the generic prescriptions itself.
ADVERTISEMENT
Amazon is reportedly talking to generic drugmakers
Amazon could be getting into healthcare, and the company's reportedly had conversations with generic drugmakers about it, CNBC reports.
ADVERTISEMENT
Recommended articles
We just got another hint about Amazon's ambitions in healthcare.
CNBC reported on Thursday that Amazon has had exploratory talks with the drugmakers Sandoz, the generic drug unit of Novartis, and Mylan.
According to a note from Leerink cited by CNBC, the president of Sandoz "
ADVERTISEMENT
Amazon declined to comment. Sandoz, and Mylan did not immediately respond to a request for comment.
Shares of Mylan were up 3% on Friday, while the wholesalers were slightly down.
FOLLOW BUSINESS INSIDER AFRICA
ADVERTISEMENT
Recommended articles
Africa's gaming gold rush: Unveiling the surge in online gambling
Seven African countries added to Meta's AI service coverage
10 African countries with the lowest inflation rates in 2024
Davido launches his label Nine+ in partnership with UnitedMasters
Nigeria's economic ranking drops to fourth in Africa
Moscow inaugurates its House of Africa
The CBN justifies $2b billion loss in forex, dispelling Naira defense claims
10 best airports in Africa in 2024
